Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cutaneous mastocytoma is a form of cutaneous mastocytosis (CM) generally characterized by the presence of a solitary or multiple hyperpigmented macules, plaques or nodules associated with abnormal accumulation of mast cells in the skin.
Features include very common findings: Darier's sign; and common findings: Pruritus, Hypermelanotic macule, Diarrhea, and Macule and others. 30 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 15 | Pruritus, Hyperpigmented papule, Erythematous papule |
Biomarker and diagnostic research for cutaneous mastocytoma has been reported in the published literature.
Phenotype severity distribution: 1 very common feature, 10 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for cutaneous mastocytoma.
14 publications have been identified in PubMed for cutaneous mastocytoma. Research spans Case Report / Case Series (38%), Diagnostic / Biomarker (23%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 38% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:30 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
4 |
Diarrhea, Vomiting, Nausea |
Lungs and breathing | 1 | Dyspnea |
Brain and nerves | 1 | Headache |
Eyes | 1 | Telangiectasia macularis eruptiva perstans |
3 |
23% |
Disease patterns and progression | 3 | 23% |
Research summaries | 2 | 15% |
Sechi A (2026). [PMID: 42171010](https://pubmed.ncbi.nlm.nih.gov/42171010/). *J Ultrasound Med*. [Diagnostic / Biomarker]
Bennani K (2026). [PMID: 42226882](https://pubmed.ncbi.nlm.nih.gov/42226882/). *Cureus*. [Case Report / Case Series]
Alhusaini RA (2026). [PMID: 41918664](https://pubmed.ncbi.nlm.nih.gov/41918664/). *Cureus*. [Case Report / Case Series]
Carter MC (2026). [PMID: 41285204](https://pubmed.ncbi.nlm.nih.gov/41285204/). *The journal of allergy and clinical immunology. In practice*. [Review / Meta-Analysis]
Suneja P (2025). [PMID: 39235109](https://pubmed.ncbi.nlm.nih.gov/39235109/). *Diagnostic cytopathology*. [Case Report / Case Series]
Engdahl K (2025). [PMID: 40480097](https://pubmed.ncbi.nlm.nih.gov/40480097/). *Preventive veterinary medicine*. [Epidemiology / Natural History]
Del Río-Sancho S (2025). [PMID: 38965056](https://pubmed.ncbi.nlm.nih.gov/38965056/). *International journal of dermatology*. [Diagnostic / Biomarker]
Muneishi Y (2025). [PMID: 41277653](https://pubmed.ncbi.nlm.nih.gov/41277653/). *European journal of dermatology : EJD*. [Case Report / Case Series]
Madigan LM (2025). [PMID: 40392511](https://pubmed.ncbi.nlm.nih.gov/40392511/). *American journal of clinical dermatology*. [Review / Meta-Analysis]
Maciulevičius M (2025). [PMID: 40425716](https://pubmed.ncbi.nlm.nih.gov/40425716/). *Scientific reports*. [Diagnostic / Biomarker]